Publications by authors named "X Bengoetxea"

Article Synopsis
  • ALS is a neurodegenerative disorder that affects both motor neurons and skeletal muscle, with muscle metabolic disruptions appearing before the onset of classic symptoms.
  • Research found that ALS muscle cells show impaired myogenesis and glucose oxidation, linked to the FOXO1 transcription factor, suggesting this factor plays a critical role in the disease's muscle-related issues.
  • Targeting FOXO1 may offer a new therapeutic strategy for ALS by improving muscle function and potentially alleviating some symptoms associated with the disorder.
View Article and Find Full Text PDF

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder that leads to progressive degeneration of motor neurons (MNs) and severe muscle atrophy without effective treatment. Most research on ALS has been focused on the study of MNs and supporting cells of the central nervous system. Strikingly, the recent observations of pathological changes in muscle occurring before disease onset and independent from MN degeneration have bolstered the interest for the study of muscle tissue as a potential target for delivery of therapies for ALS.

View Article and Find Full Text PDF

Background: A nonsynonymous single nucleotide polymorphism in the neuropeptide S receptor 1 (NPSR1) gene (rs324981) results in isoleucine-to-asparagine substitution at amino acid 107. In humans, the ancestral variant (NPSR1 I107) is associated with increased anxiety sensitivity and risk of panic disorder, while the human-specific variant (NPSR1 N107) is considered protective against excessive anxiety. In rodents, neurobiological constituents of the NPS system have been analyzed in detail and their anxiolytic-like effects have been endorsed.

View Article and Find Full Text PDF

Background: Nuclei located in the dorsal midline thalamus, such as the paraventricular nucleus of the thalamus (PVT), are crucial to modulate fear and aversive behaviour. In addition, the PVT shows a dense expression of µ-opioid receptors (MORs) and could mediate the anxiolytic effects of opioids.

Methods: We analysed the contribution of MORs in the dorsal midline thalamus (i.

View Article and Find Full Text PDF

Brain µ-opioid receptors (MOR) mediate reward and help coping with pain, social rejection, anxiety and depression. The dorsal midline thalamus (dMT) integrates visceral/emotional signals and biases behavior towards aversive or defensive states through projections to the amygdala. While a dense MOR expression in the dMT has been described, the exact cellular and synaptic mechanisms of µ-opioidergic modulation in the dMT-amygdala circuitry remain unresolved.

View Article and Find Full Text PDF